Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost.
about
The management of glaucoma and intraocular hypertension: current approaches and recent advances24-h Efficacy of Glaucoma Treatment OptionsChanges to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprostComparative study of the stability of bimatoprost 0.03% and latanoprost 0.005%: a patient-use studyProspective, non-interventional, multicenter study of the intraocular pressure-lowering effects of prostaglandin analog/prostamide-containing therapies in previously treated patients with open-angle glaucoma or ocular hypertension.Bimatoprost in the treatment of eyelash hypotrichosisClinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertensionHirsutism following the use of bimatoprost eyedrops for glaucomaComparing the efficacy of latanoprost (0.005%), bimatoprost (0.03%), travoprost (0.004%), and timolol (0.5%) in the treatment of primary open angle glaucomaProstamides (prostaglandin-ethanolamides) and their pharmacology.Glaucoma management: relative value and place in therapy of available drug treatments.Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension.Patterns of opioid analgesic prescription among patients with osteoarthritis.Efficacy and Safety of Switching Latanoprost Monotherapy to Bimatoprost Monotherapy or Combination of Brinzolamide and Latanoprost.Predictive value of the efficacy of glaucoma medications in regulatory trials: Phase I-III to post-marketing studies.Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trialsFirst-line treatment for elevated intraocular pressure (IOP) associated with open-angle glaucoma or ocular hypertension: focus on bimatoprostLatanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: a review.Bimatoprost - a review.Pharmacotherapy of intraocular pressure - part II. Carbonic anhydrase inhibitors, prostaglandin analogues and prostamides.A review of the use of latanoprost for glaucoma since its launch.Latanoprost in the treatment of glaucoma.Emerging drugs to treat glaucoma: targeting prostaglandin F and E receptors.Patient considerations in ocular hypertension: role of bimatoprost ophthalmic solution.Upregulation of orphan nuclear receptor Nur77 following PGF(2alpha), Bimatoprost, and Butaprost treatments. Essential role of a protein kinase C pathway involved in EP(2) receptor activated Nur77 gene transcription.Bimatoprost effects on aqueous humor dynamics in monkeys.Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin-ethanolamides) in the feline iris.Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study.Reporting of noninferiority and equivalence randomized trials for major prostaglandins: a systematic survey of the ophthalmology literature.The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy.Ocular effects of topical 0.03% bimatoprost solution in normotensive feline eyes.
P2860
Q22305849-F01A0AA1-EE49-4A89-AC77-48482A7A589BQ26766594-90970320-11BB-42BF-977F-C2E90B3CFF0EQ28305613-784CCF64-4A9F-48C6-8676-040A4D2E8503Q33343120-CD30B719-35D9-47E3-AC72-033D5425F6B0Q33596855-9E21C6D5-EF5E-4055-BF81-1690C413178AQ33819865-391BE857-84AD-449E-A0F0-D5018A289FF4Q34043309-5A9505C4-7B56-4BE8-8D0B-E7729511C448Q34145067-3E76C13D-A95F-40B5-887F-6A3CD60E3D6BQ34263238-06856590-9DFE-466F-B123-829F984B570BQ34667670-D6C763A3-767E-42AE-AA27-04FBB08A327DQ35079342-DD65DFF4-5714-4340-A6CC-6EB99E3AD911Q35237431-DB92E220-AE0F-4CAE-9D2C-3C487935893EQ35590426-74C9186E-9100-439F-A020-5048120EEEACQ35775628-42ECEB0C-6790-44C4-BB63-C4CDB6375A16Q36709208-55E4775D-2804-4D0C-ABC7-D421C00EF4C5Q36856440-D85F841A-1F57-458B-B40E-9AE64BC28989Q37091331-B866B21B-9B51-4E34-99BA-2961E435E232Q37239287-E82A9BCF-05F7-4693-B0D8-C721B36E3E06Q37577392-4A12DB5F-C441-406A-B52B-22BF5D8BD9C7Q37623833-29FA3E90-E579-4FD0-ACB3-5605D8ACF3BBQ37636153-0811EE3B-625A-4B0B-A796-D569680AF304Q37986149-A4B57237-FD0E-4C79-9EF2-64D392177EDBQ38261310-2DE5B80C-C705-49DE-80C5-2100EE351CD7Q38725839-73EADFDF-6ABB-4C05-B261-E523658D1D1CQ39458214-70387A68-A1CE-4ECF-96CE-061D1BA9FE92Q40552681-11553CFB-D408-46A2-84F6-CFFC739E960BQ40700760-AEFDBF79-1B78-41C8-B3B5-158A3D300165Q41585257-08218F8A-8A77-43ED-9EA6-AB8E46A1D9B4Q41828491-0AD07473-CC2A-45B0-AE46-0222895B25EAQ42029736-797E0508-73F1-4DEC-B8C3-A2FC2BCBCE0FQ46846456-4F07E98F-D3D7-45AD-A785-6D7DBF0339FFQ46892080-8D4800B6-7BAD-4C33-AB24-21A4FA077C6D
P2860
Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Efficacy and safety of bimatop ...... y comparison with latanoprost.
@en
Efficacy and safety of bimatop ...... y comparison with latanoprost.
@nl
type
label
Efficacy and safety of bimatop ...... y comparison with latanoprost.
@en
Efficacy and safety of bimatop ...... y comparison with latanoprost.
@nl
prefLabel
Efficacy and safety of bimatop ...... y comparison with latanoprost.
@en
Efficacy and safety of bimatop ...... y comparison with latanoprost.
@nl
P2093
P1476
Efficacy and safety of bimatop ...... y comparison with latanoprost.
@en
P2093
P304
P356
10.1016/S0039-6257(01)00212-0
P478
45 Suppl 4
P577
2001-05-01T00:00:00Z